To gain further insights into genotype–phenotype correlations and potential epigenotype alterations in SETD1A and SETD2-related neurodevelopmental disorders, we undertook genome-wide methylation profiling studies of ~2 M CpGs in these conditions and assessed the methylation episignatures of these disorders. The gene discussed is SETD1A; the disease is neurodevelopmental disorder.